For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Medical simulation is the modern day methodology for training healthcare professionals through the use of advanced educational technology. Simply put, medical simulation is the experiential learning every healthcare professional will need, but cannot always engage in during real-life patient care. Medical simulation has also been called healthcare simulation, simulation in healthcare, patient simulation, nursing simulation, surgical simulation and clinical simulation.
Scope of the Report:
This report studies the Medical Simulation market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Medical Simulation market by product type and applications/end industries.
The medical simulation industry concentration is not high; top ten manufacturers took up about 55% of the global market, and high-end products mainly from America and European. In the world wide, giant manufactures mainly distribute in North America and Europe. North America has a long history and unshakable status in this industry, like Simulaids and Gaumard Scientific, both have perfect products, the CAE Healthcare has become a global leader since it acquired METI in 2011. In Europe, Laerdal Medical leads the technology development and market. The Chinese manufacturers are manly in Shanghai, Beijing and Tianjin.
Medical simulation industry is closely to be mature these years, and the consumption growth rate will show a smooth curve in the next few years. The average product prices has a slow downward trend with the rate of 2.8%-4.3% in recent years, and it will maintain in near future.
North America is the largest market of medical simulation, with the share of about 40% in the past five years, flowed by Europe (About 25%). There are mainly low-end products in chinese market, the production value is only 8% of the world, while the production is about 15%. The chinese product price is nearly 1/2 of the global average price.
Although sales of medical simulation brought a lot of opportunity, the study group recommends the new entrants just having money but without technical advantage and downstream support do not to enter into the semiconductor silicon wafer field.
The global Medical Simulation market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Medical Simulation.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Laerdal Medical
- CAE Healthcare
- Surgical Science
- Kyoto Kagaku
- Gaumard Scientific
- Limbs & Things
- Shanghai Honglian
- Yimo Keji
- Shanghai Kangren
- Shanghai Yilian
- Shanghai Boyou
- Shanghai Zhineng
- Shanghai Bezer
- Shanghai Yikang
- Shanghai Shengjian
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Medical colleges
- Medical traing institions